Enovis (ENOV)
NYSEHealth CareMedical - DevicesSnapshot 2026-11-04
$28.62+17.20%
Close 2026-11-05 · 1-day change
NYSEHealth CareMedical - DevicesSnapshot 2026-11-04
QuarterlyIQ Insights · ENOV
Next print, the company's guidance track record, and the earnings events we've seen in the last few years.
Likelihood the company beats analyst consensus on its next print. Read from its own beat history plus how sector peers have been reporting. Not a price-direction call: a serial beater often has the beat already priced in.
Prints it beat consensus, recent quarters.
Indicative, not a guarantee. Base rate ~71%.
Industry peers that beat since this name last reported.
Management's most recent EPS guidance action.
expected = 0.35*own_median(6.9) + peer(0.2*5.3) + term(0.0) → 3.46% (capped ±15.0)
Average absolute move on past earnings days.
Annualized: recent baseline volatility.
Of the last 0 guided quarters.
Actual vs. guided EPS, signed.
Excess return vs. sector ETF, day after print.
Earnings prints and pre-announcements detected in the SEC filing stream.
Results of Operations and Financial Condition. On November 5, 2026, the Company issued a press release reporting financial results for the third quarter ended October 2, 2026. A copy of the Company's press release is attached to this report as Exhibit 99.1 and is incorporated into
Quarterly EPS and revenue actuals vs. consensus across the last eight quarters (including beat/miss size and the forward consensus heading into the next print) are on the way.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Results of Operations and Financial Condition. On August 6, 2026, the Company issued a press release reporting financial results for the second quarter ended July 3, 2026. A copy of the Company's press release is attached to this report as Exhibit 99.1 and is incorporated into
Results of Operations and Financial Condition. On May 7, 2026, the Company issued a press release reporting financial results for the first quarter ended April 3, 2026. A copy of the Company's press release is attached to this report as Exhibit 99.1 and is incorporated into
Results of Operations and Financial Condition. On February 26, 2026, the Company issued a press release reporting financial results for the year ended ended December 31, 2025. A copy of the Company's press release is attached to this report as Exhibit 99.1 and is incorporated into
Results of Operations and Financial Condition. On November 6, 2025, the Company issued a press release reporting financial results for the third quarter ended October 3, 2025. A copy of the Company's press release is attached to this report as Exhibit 99.1 and is incorporated into
Results of Operations and Financial Condition. On August 7, 2025, the Company issued a press release reporting financial results for the second quarter ended July 4, 2025. A copy of the Company's press release is attached to this report as Exhibit 99.1 and is incorporated into
Results of Operations and Financial Condition. On May 8, 2025, the Company issued a press release reporting financial results for the first quarter ended April 4, 2025. A copy of the Company's press release is attached to this report as Exhibit 99.1 and is incorporated into
Results of Operations and Financial Condition. On February 26, 2025, the Company issued a press release reporting financial results for the year ended ended December 31, 2024. A copy of the Company's press release is attached to this report as Exhibit 99.1 and is incorporated into
Results of Operations and Financial Condition. On November 6, 2024, the Company issued a press release reporting financial results for the third quarter ended September 27, 2024. A copy of the Company's press release is attached to this report as Exhibit 99.1 and is incorporated into
Results of Operations and Financial Condition. On August 7, 2024, the Company issued a press release reporting financial results for the second quarter ended ended June 28, 2024. A copy of the Company's press release is attached to this report as Exhibit 99.1 and is incorporated into
Results of Operations and Financial Condition. On May 2, 2024, the Company issued a press release reporting financial results for the first quarter ended ended March 29, 2024. A copy of the Company's press release is attached to this report as Exhibit 99.1 and is incorporated into
Results of Operations and Financial Condition. On February 22, 2024, the Company issued a press release reporting financial results for the year ended ended December 31, 2023. A copy of the Company's press release is attached to this report as Exhibit 99.1 and is incorporated into
Results of Operations and Financial Condition. On November 7, 2023, the Company issued a press release reporting financial results for the third quarter ended ended September 29, 2023. A copy of the Company's press release is attached to this report as Exhibit 99.1 and is incorporated into
Results of Operations and Financial Condition. On October 19, 2023, Enovis Corporation (the “Company”) released the following preliminary information about its performance for the third quarter ended September 29, 2023. Revenues for the three months ended September 29, 2023 are expected to be between $414 and $418 million, compared to approximately $383 million for the three months ended September 30, 2022, representing an increase of approximately 8 to 9%. Adjusted EBITDA for the three month…
Results of Operations and Financial Condition. On August 3, 2023, the Company issued a press release reporting financial results for the second quarter ended ended June 30, 2023. A copy of the Company's press release is attached to this report as Exhibit 99.1 and is incorporated into
Results of Operations and Financial Condition. On May 4, 2023, the Company issued a press release reporting financial results for the first quarter ended ended March 31, 2023. A copy of the Company's press release is attached to this report as Exhibit 99.1 and is incorporated into